Back to top
more

Phibro Animal Health (PAHC)

(Delayed Data from NSDQ)

$17.07 USD

17.07
114,274

+0.31 (1.85%)

Updated May 3, 2024 04:00 PM ET

After-Market: $17.05 -0.02 (-0.12%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (151 out of 252)

Industry: Medical - Products

Better trading starts here.

Zacks News

Should You Sell Phibro Animal Health (PAHC) Before Earnings?

Given that Phibro Animal Health (PAHC) has a Zacks Rank #3 (Hold) and an ESP in positive territory, investors might want to consider this stock ahead of earnings.

    Phibro (PAHC) Strong on Animal Health Arm, Dull MFA Ails

    Phibro's (PAHC) Animal Health segment has been a key contributor to growth over the last few quarters. MFA remains soft in the United States due to sales decline of medically important antimicrobials.

      Dull MFA & Mineral Nutrition Sales Hurt Phirbo, Rivalry Rife

      Phibro's (PAHC) Medicated feed additives (MFA) business was weak in the United States. Also, a persistent decline in Mineral Nutrition segment sales is likely to raise concern.

        Phibro Animal (PAHC) Beats on Q1 Earnings, Reiterates View

        Phibro Animal (PAHC) witnesses year-over-year improvement across all segments in Q1.

          Phibro Animal Banks on Diverse Portfolio, Competition Rife

          Phibro Animal (PAHC) is consistently trying to expand its product portfolio to counter the tough competition in the animal health space.

            Phibro (PAHC) Down 2.7% Since Earnings Report: Can It Continue?

            Phibro (PAHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

              Phibro Animal Health Expands Globally Amid Tough Competition

              Phibro (PAHC) is consistently trying to expand globally to counter the tough competition in the animal health and mineral nutrition space.

                Phibro Animal (PAHC) Beats Q4 Earnings & Sales Estimates

                Phibro Animal (PAHC) reported solid fourth-quarter fiscal 2017 revenues on the back of sales growth in the Animal Health, Mineral Nutrition and Performance Products segments.

                  Phibro Animal Health & Zydus Cadila Plan to Expand in India

                  Phibro Animal Health Corporation (PAHC) recently announced plans to enter into a long-term agreement with global pharmaceutical company Zydus Cadila to expand in the rapidly growing poultry market in India.

                    Health Care Battle Rages On: 2 MedTech Stocks to Buy

                    Let's focus on two MedTech Stocks which are fundamentally strong amidst the volatile market condition.

                      Here's Why Phibro Animal Health Is Worth Buying Right Now

                      Phibro Animal Health Corporation (PAHC), has rallied 24.2% over the past three months, ahead of the S&P 500's mere 2.6% gain.

                        Phibro Animal Health (PAHC) Rides High on Solid Prospects

                        On Jun 12, we issued an updated research report on NJ-based Phibro Animal Health Corporation (PAHC) ??? a leading global diversified animal health and mineral nutrition company.

                          Phibro Animal Health (PAHC) Up 10% Since Earnings Report: Can It Continue?

                          Phibro Animal Health (PAHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                            Can The Uptrend Continue for Phibro Animal Health (PAHC)?

                            Investors certainly have to be happy with Phibro Animal Health Corp (PAHC) and its short term performance

                              Phibro (PAHC) Posts In Line Earnings in Q3, Revises View

                              Phibro Animal Health Corporation (PAHC) reported adjusted earnings per share (EPS) of 37 cents in the third quarter of fiscal 2017, down 7.5% year over year.

                                Why Is Phibro (PAHC) Down 7% Since the Last Earnings Report?

                                Phibro (PAHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                                  Phirbo Animal (PAHC) Tops Q2 Earnings, Reaffirms FY17 View

                                  Phibro Animal Health Corporation (PAHC) reported adjusted earnings per share (EPS) of 39 cents in the second quarter of fiscal 2017.

                                    Medical Product Stocks' Earnings on Feb 6: HAE, PAHC & More

                                    Let's take a look at the major Medical products stocks slated to release their quarterly reports on Feb 6.